Emily Nash Smyth

Sensory dominance and multisensory integration as screening tools in aging

Micah M. Murray, Alison F. Eardley, Trudi Edginton et al. · Scientific Reports · 2018 · 73 citations · Full text

Social Sciences, Neuroscience, Psychology +17

Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer

Jin Hyoung Kang, David C. Smith, Richard K. Rosenberg et al. · Investigational New Drugs · 2016 · 68 citations

Medicine, Oncology, Pharmacology +12

Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer

Emily Nash Smyth, Wei Shen, Lee Bowman et al. · Health and Quality of Life Outcomes · 2016 · 41 citations · Full text

Medicine, Oncology, Breast Oncology +15

Real-world treatment patterns and outcomes of abemaciclib for the treatment of HR+, HER2− metastatic breast cancer

Gebra Cuyún Carter, Kristin M. Sheffield, Anala Gossai et al. · Current Medical Research and Opinion · 2021 · 39 citations

Medicine, Oncology, Pharmacotherapy +17

Physical Therapists in Oncology Settings: Experiences in Delivering Cancer Rehabilitation Services, Barriers to Care, and Service Development Needs

Louise Brennan, Gráinne Sheill, Linda O’Neill et al. · Physical Therapy · 2022 · 39 citations · Full text

Medicine, Oncology, Cancer Rehabilitation +9